PRDM9 and glaucoma: Dysregulated expression of histone-modifying enzymes, such as histone deacetylases (HDACs) and histone methyltransferases (HMTs), has been implicated in glaucoma pathogenesis, underscoring their potential as diagnostic biomarkers [109,110,111,112,113,114].